« Glucagon-like Peptide-1 Medicines for Peripheral Arterial Disease in Type 2 Diabetes: Are They Ready for Prime Time? », Can Diabetes Endocrinol Today, vol. 4, nᵒ 1, p. 5–9, mai 2026, doi: 10.58931/cdet.2026.4149.